2020, A Year in Review
Startup Nursery Q3 2020 Insight
October 28, 2020
As we enter the last quarter of 2020, the US and the world have crossed grim milestones with COVID. With over eight million cases in the US and thirty-nine million worldwide, and over two hundred thousand deaths in the US and over one million worldwide, the human price of this pandemic is mind-boggling.
About Us
Ikove is a venture development company founded to pursue early-stage investments with an emphasis on technology commercialization. Through its proprietary Startup Nursery, in partnership with multiple U.S. research institutions, Ikove identifies and validates developing high-impact technologies, providing capital and commercialization resources to bridge the gap between R&D and VC funded rounds.
Portfolio Companies
Our Process
We go to the source
Ikove pursues technologies that have been developed and reinforced by significant investments in R&D at leading research institutions. Technologies are vetted through our Startup Nursery, and if they survive, we recruit CEOs and operators to be part of the founding cap table of the companies.
We Focus Where Few are Looking
We are headquartered in the Midwest, where we have access to world-class technologies, infrastructure and teams at a fraction of the cost of the East and West Coasts. Our CEOs can relocate the companies where they see a strategic fit but still have the benefits of lower costs and valuation arbitrage as the operating businesses settles in places like San Francisco, New York City or Hong Kong.
We are Founders
Ikove is heavily involved in the launch and operations of the business alongside each company’s management team. We focus on deep tech businesses instead of investing in or developing the latest trending app; we prefer to focus on disrupting industries that are backed by strong and significant IP.
We Invest in Painkillers Not in Vitamins
We invest in deep tech that solves big problems with significant market potential and are backed by strong intellectual property.
Build to Sell
We build our companies to become fast-growing, profitable businesses that can go all the way to IPOs; but given current exit dynamics, we position our portfolio companies in a way that they can be acquisition targets. We develop our companies with a clear “build-to-sell” focus.
Stay away from negative people. They have a problem for every solution.
If you want to go fast, go alone. If you want to go far, go together.
Great things in business are never done by one person. They're done by a team of people.
Never doubt that a small group of thoughtful, committed people can change the world. Indeed it is the only thing that ever has.
Coming together is a beginning. Keeping together is progress. Working together is success.
Latest News
2019 Year In Review
Subscribe to Ikove Insights
Enter your email address to subscribe to Ikove Insights delivered right to your inbox.
